Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

$19.04 0.23 (1.20%)

14:40 EDT AMLX Stock Quote Delayed 30 Minutes

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List

By Chris Markoch, InvestorPlace Contributor Aug 28, 2023

Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.

3 Biotech Stocks to Buy Before Drug Trials End

7 Biotech Stocks to Buy for 100% Returns

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 424,837

Day's Range $18.73 - $19.24

52-Week Range $17.80 - $41.93

Dividend & Yield N/A (N/A)

AMLX Stock Predictions, Articles, and Amylyx Pharmaceuticals, Inc. - Common Stock News

From InvestorPlace
From the Web

AMLX Stock Alert: Amylyx Pharma Gains on Huge FDA Win

By Joel Baglole, InvestorPlace Contributor Sep 30, 2022

Shares of Amylyx Pharma are popping today on news that the FDA has greenlit its treatment against the deadly disease ALS.

Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 70% Today?

By William White, InvestorPlace Writer Sep 8, 2022

Amylyx Pharmaceuticals (AMLX) stock is rocketing higher on Thursday following an update from the FDA on its ALS treatment.

7 Biotech Stocks to Buy for Q3

By Shanthi Rexaline Jul 18, 2022

These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.

Amylyx (AMLX) Stock Spikes 13% as FDA Resumes Discussion of ALS Drug

By David Moadel, InvestorPlace Contributor Jul 5, 2022

A new wrinkle in the story of Amylyx Pharmaceuticals' ongoing battle against ALS bodes well for patients, and for AMLX stock holders.

Why Is Amylyx Pharmaceuticals (AMLX) Stock Up 23% Today?

By William White, InvestorPlace Writer Jun 3, 2022

Amylyx Pharmaceuticals (AMLX) stock is rising higher on Friday following an update from the U.S. Food and Drug Administration (FDA).

7 Biotech Stocks With Key Catalysts in March

By Shanthi Rexaline Mar 9, 2022

These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.

Amylyx Pharmaceuticals GAAP EPS of $0.31 beats by $0.35, revenue of $98.2M beats by $6.06M (NASDAQ:AMLX)

From Seeking Alpha Aug 10, 2023

Amylyx Pharmaceuticals press release (NASDAQ:AMLX): Q2 GAAP EPS of $0.31 beats by $0.35.Revenue of $98.2M beats by $6.06M.

Amylyx up 5% on Goldman Sachs upgrade to buy (NASDAQ:AMLX)

From Seeking Alpha Jul 24, 2023

Goldman Sachs has upgraded Amylyx to buy saying that a downturn in the stock as some investors are worried about the results of a study are overdone. Read more here.

Why Shares of Amylyx Pharmaceuticals Were Up Monday

From The Motley Fool Jul 24, 2023

The company got a bump from an analyst's upgrade.

EMA panel gives negative opinion on Amylix ALS drug application (AMLX)

From Seeking Alpha Jun 23, 2023

Amylix (AMLX) said that an European Medicines Agency advisory committee has given a negative opinion on the EU market application for its drug AMX0035 in the treatment of ALS.

Better Growth Stock: Amylyx Pharmaceuticals or Viking Therapeutics?

From The Motley Fool Jun 13, 2023

Which of these red-hot biotech stocks is the better buy right now?

2 Supercharged Growth Stocks to Buy Right Now

From The Motley Fool May 14, 2023

These two biopharma stocks might be poised for a major breakout.

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List

3 Biotech Stocks to Buy Before Drug Trials End

7 Biotech Stocks to Buy for 100% Returns

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

AMLX Stock Predictions, Articles, and Amylyx Pharmaceuticals, Inc. - Common Stock News

Subscriber Sign in